Malaria Medicine Shortage Announced

The U.S. Food and Drug Administration Current and Resolved Drug Shortages and Discontinuations Report says as of May 14, 2024, Teva Pharmaceuticals USA, Inc. mefloquine hydrochloride tablet medication (Tablet, 250 mg, NDC 0555-0171-78) is in limited supply through August 2024.

The company's contact number is 800-545-8800.

In 2024, the Pan American Health Organization estimated that approximately 41 million people are living in areas where the risk of infection by mosquito-carrying Malaria is considered moderate to high. Most malaria infections in the United States and its territories occur among persons who have traveled to regions with ongoing malaria transmission.

While Teva's product shortage may disrupt summer vacation plans, pharmacists and travel clinics may offer alternative products.

As of May 15, 2024, numerous malaria cases have been reported in the United States in 2024.

While two malaria vaccines are available in Africa, neither are offered in the United States.